Articles · Symptoms
Dry Eye After Menopause
Androgens, not estrogen, control tear film quality, and HRT may make symptoms worse.
Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.
Dry eye syndrome affects women at roughly twice the rate it affects men, and the gap widens after menopause.[1] Many postmenopausal women who develop dry, gritty, or burning eyes assume that restoring estrogen will help. The research suggests the opposite may be true.
Understanding why means understanding which hormones actually regulate tear production.
What Dry Eye Syndrome Is
The tear film is not just water. It is a three-layer structure: an inner mucous layer, a middle watery layer, and an outer oily layer. The oily layer, made by the meibomian glands in the eyelids, keeps the watery layer from evaporating between blinks.
When the oily layer runs short, the tear film breaks up quickly, exposing the eye surface to air. The result is dryness, irritation, burning, and a feeling of something in the eye, and sometimes, oddly, excess reflex tearing, as the eye responds to dryness by making more watery tears that evaporate just as fast.
The most common form of dry eye in postmenopausal women is evaporative, driven by meibomian gland dysfunction rather than too little watery tear production. This distinction matters for treatment.
The Androgen Connection
Meibomian glands are androgen-sensitive. Androgen receptors sit on meibomian gland cells, and androgens drive the production and release of the oils that form the outer tear layer.[2] When androgen levels fall, as they do gradually through midlife, meibomian gland function declines, oil production drops, and the tear film becomes unstable.
Low androgen levels are a more significant factor in dry eye disease than low estrogen levels.[2] Women with complete androgen insensitivity syndrome, whose cells cannot respond to androgens, have severe meibomian gland shrinkage and dry eye as a characteristic feature. Women with other androgen-deficient states show similar patterns.
Why Estrogen May Worsen Dry Eye
Estrogen suppresses oil production in sebaceous glands, including the meibomian glands.[2][3] Animal models given estrogen show shrinkage and reduced activity of these glands. Population data in humans show that postmenopausal women on estrogen-containing HRT have higher rates of dry eye symptoms than those not on HRT.
A meta-analysis of randomized trials found that sex hormone replacement therapy (estrogen alone or combined with progestogen) produced limited benefit for dry eye symptoms and, on some measures, worsened meibomian gland function and tear film stability.[3]
This does not mean HRT is off-limits for women with dry eye. The other benefits of HRT may outweigh this concern for many women. It does mean HRT should not be expected to improve dry eye, and women who notice worsening symptoms after starting HRT should raise it with their prescriber.
Prevalence and Timing
US population data find that women over 50 have roughly double the dry eye rate of men over 50 (7% versus 4%), with the gap widening with age after menopause.[1] The risk is 50 to 70% higher in women than men overall, with menopause as a clear inflection point.
Onset during perimenopause or early postmenopause fits the hormonal mechanism: androgens decline gradually through midlife, and many women reach the point where meibomian gland function becomes insufficient during this transition.
What Actually Helps
Warm compresses and eyelid hygiene. The first-line approach for evaporative dry eye is physically unblocking the meibomian glands. A heated eye bag applied for 10 to 15 minutes softens oil secretions that have solidified or thickened. Gentle eyelid massage after the compress presses out the treated oil and helps clear the gland openings. Regular practice improves the oily layer.
Artificial tears. Preservative-free drops provide symptom relief. For evaporative dry eye specifically, oil-containing formulations may work better than water-only drops, since they target the deficient outer layer directly.
Omega-3 supplementation. EPA and DHA improve the quality of meibomian secretions. Randomized trials have found that omega-3 supplementation reduces tear evaporation and dry eye symptoms compared with placebo, with effects appearing over several months.[4]
Androgen-based approaches. There is growing evidence for androgen supplementation as a targeted treatment for meibomian gland dysfunction. Topical androgen formulations applied to the eyelid margin and androgen-containing eye drops are in clinical trials and have shown promising early results. This remains investigational.
Humidification and environment. Low-humidity environments (air-conditioned offices, aircraft cabins) speed up evaporative loss. A humidifier in the bedroom and workplace, and deliberate blinking during screen work, are practical low-risk measures.
When to See an Eye Specialist
Dry eye that does not respond to over-the-counter artificial tears warrants assessment by an ophthalmologist or optometrist with expertise in dry eye. Blepharitis, meibomian gland disease, and other causes of ocular surface disease need specific clinical diagnosis and management.
References
[1] Schaumberg, D. A., Sullivan, D. A., Buring, J. E., Dana, M. R. (2003). Prevalence of dry eye syndrome among US women. American Journal of Ophthalmology, 136(2), 318-326. See also: Dry eye syndrome in menopause and perimenopausal age group. https://pmc.ncbi.nlm.nih.gov/articles/PMC5496280/
[2] Sullivan, D. A., Rocha, E. M., Aragona, P., et al. (2017). TFOS DEWS II sex, gender, and hormones report. The Ocular Surface, 15(3), 284-333. See also: Hormones and dry eye disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC10276676/
[3] Feng, Y., Feng, G., Xu, L., et al. (2019). Sex hormone therapy’s effect on dry eye syndrome in postmenopausal women: A meta-analysis of randomized controlled trials. Medicine, 98(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC6200492/
[4] Deinema, L. A., Vingrys, A. J., Wong, C. Y., et al. (2017). A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease. Ophthalmology, 124(1), 43-52. https://doi.org/10.1016/j.ophtha.2016.09.023
Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.